Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients
Article first published online: 24 APR 2014
© 2014 British Society for Immunology
Clinical & Experimental Immunology
Volume 176, Issue 3, pages 401–409, June 2014
How to Cite
Saison, J., Ferry, T., Demaret, J., Maucort Boulch, D., Venet, F., Perpoint, T., Ader, F., Icard, V., Chidiac, C., Monneret, G. and Lyon HIV Cohort Study (2014), Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients. Clinical & Experimental Immunology, 176: 401–409. doi: 10.1111/cei.12278
- Issue published online: 24 APR 2014
- Article first published online: 24 APR 2014
- Accepted manuscript online: 27 JAN 2014 03:42AM EST
- Manuscript Accepted: 18 JAN 2014
- Hospices Civils de Lyon
- Beckman Coulter
Fig. S1. Gating strategy.
Table S1. Descriptive analysis of CD4+ T cells and regulatory T cell (Treg) subsets as absolute counts according to the immune response to highly active anti-retroviral therapy (HAART) (n = 87). Total activated CD4+ T cells CD4+human leucocyte antigen D-related (HLA-DR)+ T cells; Tregs CD4+CD25+forkhead box protein 3 (FoxP3)+ T cells; effector Tregs: CD4+CD25+FoxP3+CD45RA– T cells; terminal effector Tregs: CD4+CD25+FoxP3+CD45RA– HLA-DR+ T cells; effectors (non-Tregs) CD4+ T cells: CD4+FoxP3–HLA-DR+ T cells; activated effector CD4+ T cells: CD4+FoxP3–HLA-DR+ T cells. Results are expressed as absolute values.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.